NanoHealth inks pact with GVK Bio

23 September 2014 | News | By BioSpectrum Bureau

NanoHealth inks pact with GVK Bio

NanoHealth will be the first to use mobile enabled and multilingual Disease Management Application on the HEART platform

NanoHealth will be the first to use mobile enabled and multilingual Disease Management Application on the HEART platform

NanoHealth in association with GVK Bio has launched holistic healthcare services for slum dwellers. NanoHealth is a social enterprise, founded by a group of ISB alumni specialising in chronic disease management.

It has partnered with GVK BIO's proprietary HEART (Health Emphasized Analytical and Reporting Tool) platform-a cloud based healthcare analytics framework with multiple applications. NanoHealth will be the first to use mobile enabled and multilingual Disease Management Application on the HEART platform to register, enroll, record, and manage patients. The application acts as an enabler, through information processing, for the right stakeholder to decide and take action for maximum impact.

Mr Shiva Subramaniam, senior vice president and head of informatics, GVK Biosciences said, "The mission of HEART is to improve general health and reduce or reverse progression of chronic diseases by building patient centric, high quality healthcare and clinical systems that are simple and accessible to all and which will enable reduction of healthcare costs for all stakeholders. We hope that the HEART platform will help manage and reduce the threat of the rapidly growing chronic diseases especially in slum dwellers where healthcare is the last priority."

NanoHealth is creating a network of community health-workers known as "Saathis" and equipping them with a diagnostic device called "Doc-in-a-Box". The doctor's reach is extended by its Saathis, who are well-paid, empowered women in the community forming a strong network of caregivers. The team conducted their pilot in Anjaiah Nagar slum in Hyderabad.

"NanoHealth is on a mission to prevent premature deaths caused due to chronic diseases in urban slums. We have a strong team and with the help of credible partners like GVK BIO, we are making progress every day," said Mr Manish Ranjan, CEO, NanoHealth.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account